The European Research Journal, Journal Year: 2025, Volume and Issue: 11(2), P. 143 - 150
Published: Feb. 4, 2025
Objectives: Individuals with myocardial infarction (MI) frequently exhibit a heightened prevalence of depression, which elevates the likelihood negative cardiovascular outcomes. This study aimed to assess potential synergistic effects sertraline, an antidepressant utilised for prevention and treatment depression commonly associated cardiac disorders, selenium, antioxidant trace element, on atrial contraction force. Methods: Thirty-two adult male Wistar albino rats were randomly allocated into four groups. Atrial strips positioned in organ bath, tension was calibrated 2 g. In control group, isometric contractions elicited using 10-3 M adrenaline, documented. Sertraline (S) incrementally administered S group dosages 0.01 mM, 0.1 1 mM. Selenium (Se) Group, selenium at concentrations 0.1, 1, 2, 4 mmol/L. S+Se cumulative (0.01 mM) Se (0.1, 4) mmol/L fifteen-minute intervals. Results: The had statistically significant reduction compared group. Statistically substantial inhibition noted relative (P=0.035 P=0.02, respectively). Conclusions: According results our study, sertraline-selenium combination showed effect by Ca2+ channels rat atrium. Additional research is needed elucidate mechanism action used that often accompanies effective element properties.
Language: Английский